|
Hey Ken!
It was fun (and educational) trying to understand the article.
Marlene, I saw that article you posted. Also very interesting. I know that sometimes, for MDS as opposed to AA, the docs want to do reduced intensity and use peripheral blood in order to get a little GVHD for the graft versus leukemia effect.
I think that post-transplant HiCY is just what Karen (mausmish) had at Hopkins.
And I do think you are right that it's much more complicated, as the docs try to get just the right mix of drugs.
Take care!
Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com
|